The DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.
Metabolic impact of combined hormonal contraceptives containing estradiol
Open accessAbstract
INTRODUCTION: Is the replacement of ethinyl-estradiol (EE) with estradiol (E2) in combined hormonal contraceptives (CHCs) associated with fewer metabolic effects, leading to a further improvement on safety of hormonal contraceptives? AREAS COVERED: This is a narrative review paper including all available data on the metabolic impact of CHCs containing E2 published in English up to December 2015. Modification of a metabolic variable of interest during the first months of treatment was considered as an outcome. EXPERT OPINION: E2 was extensively used in oral contraceptives associated to nomegestrol acetate (NOMAc) in a monophasic 24 + 4 or its ester E2 valerate to dienogest (DNG) in a quadriphasic 26 + 2 regimen. The impact on the lipid metabolism and the hemostatic system of these preparations seems milder than that caused by EE-based ones, associated with no change of blood pressure. The impact on bone metabolism was instead similar to EE. Data available in the literature are mainly derived from studies having secondary minor metabolic outcomes as the primary end-point, and so currently not completely applicable on the real variables of interest (arterial or venous cardiovascular events, bone fractures). The preliminar parenteral use of E2 seems promising, both transdermal and vaginal, in particular after the introduction of a specific progestin with a high anti-ovulatory activity, like nestorone.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Citations
Cites
Medical eligibility criteria for contraceptive use
Trussell, J. (2011) · Human Fertility · doi:10.3109/14647273.2011.602520 · Cited by 482
Lee, A. J., Cai, M. X., Thomas, P. E., Conney, A. H., & Zhu, B. T. (2003) · Endocrinology · doi:10.1210/en.2003-0192 · Cited by 456
Combined oral contraceptives: venous thrombosis
de Bastos, M., Stegeman, B. H., Rosendaal, F. R., Van Hylckama Vlieg, A., Helmerhorst, F. M., Stijnen, T., & Dekkers, O. M. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010813.pub2 · Cited by 399
Oral contraceptives and venous thromboembolism: a five-year national case-control study☆
Lidegaard, Ø., Edström, B., & Kreiner, S. (2002) · Contraception · doi:10.1016/s0010-7824(01)00307-9 · Cited by 334
Insulin resistance, secretion, and metabolism in users of oral contraceptives
Godsland, I. F. (1992) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.74.1.64 · Cited by 251
Oelkers, W. (1995) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.80.6.1816 · Cited by 246
Hannaford, P. C., Iversen, L., Macfarlane, T. V., Elliott, A. M., Angus, V., & Lee, A. J. (2010) · BMJ · doi:10.1136/bmj.c927 · Cited by 243
Nestorone®: a progestin with a unique pharmacological profile
Kumar, N. (2000) · Steroids · doi:10.1016/s0039-128x(00)00119-7 · Cited by 184
SOME EFFECTS OF ORAL CONTRACEPTIVES ON SERUM-LIPID AND LIPOPROTEIN LEVELS
Wynn, V., Doar, J. W. H., & Mills, G. L. (1966) · The Lancet · doi:10.1016/s0140-6736(66)92979-5 · Cited by 179
Blood Pressure in Women Taking Oral Contraceptives
Weir, R. J., Briggs, E., Mack, A., Naismith, L., Taylor, L., & Wilson, E. (1974) · BMJ · doi:10.1136/bmj.1.5907.533 · Cited by 164
Surrogate End Points in Clinical Research: Hazardous to Your Health
Grimes, D. A., & Schulz, K. F. (2005) · Obstetrics and Gynecology · doi:10.1097/01.aog.0000157445.67309.19 · Cited by 153
Ågren, U. M., Anttila, M., Mäenpää-Liukko, K., Rantala, M.-L., Rautiainen, H., Sommer, W. F., & Mommers, E. (2011) · The European Journal of Contraception & Reproductive Health Care · doi:10.3109/13625187.2011.604450 · Cited by 130
Dhont, M. A. (2010) · The European Journal of Contraception & Reproductive Health Care · doi:10.3109/13625187.2010.513071 · Cited by 127
Hormonal contraceptives and venous thromboembolism: An epidemiological update
Plu‐Bureau, G., Maitrot‐Mantelet, L., Hugon‐Rodin, J., & Canonico, M. (2012) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2012.11.002 · Cited by 123
The combined oral contraceptive pill- recent developments, risks and benefits
Dragoman, M. V. (2014) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2014.06.003 · Cited by 116
SERUM LIPIDS AND LIPOPROTEINS DURING LONG-TERM ADMINISTRATION OF AN ORAL CONTRACEPTIVE
Aurell, M., Cramer, K. G. M. D., & Rybo, G. (1966) · The Lancet · doi:10.1016/s0140-6736(66)90641-6 · Cited by 115
Hormonal contraception and bone metabolism: a systematic review
Nappi, C., Bifulco, G., Tommaselli, G. A., Gargano, V., & Carlo, C. D. (2012) · Contraception · doi:10.1016/j.contraception.2012.04.009 · Cited by 111
Klipping, C., Duijkers, I. J. M., Parke, S., Mellinger, U., Serrani, M., & Junge, W. (2011) · Drugs in R&D · doi:10.2165/11591200-000000000-00000 · Cited by 110
Junge, W., Mellinger, U., Parke, S., & Serrani, M. (2011) · Clinical Drug Investigation · doi:10.2165/11590220-000000000-00000 · Cited by 107
Approach to the Patient: Contraception in Women With Polycystic Ovary Syndrome
Yıldız, B. O. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-3196 · Cited by 103
Mansour, D., Verhoeven, C., Sommer, W., Weisberg, E., Taneepanichskul, S., Melis, G. B., Poromaa, I. S., & Korver, T. (2011) · The European Journal of Contraception & Reproductive Health Care · doi:10.3109/13625187.2011.614029 · Cited by 102
Alhenc‐Gelas, M., Thomas, J.-L., Bachelot‐Loza, C., Remones, V., Ali, F. D., Aiach, M., Scarabin, P., & Gaussem, P. (2011) · Thrombosis and Haemostasis · doi:10.1160/th10-05-0327 · Cited by 101
Gambacciani, M., Spinetti, A., Taponeco, F., Cappagli, B., Piaggesi, L., & FIORETTI, P. (1994) · PubMed · Cited by 99
Does dienogest influence the inflammatory response of endometriotic cells? A systematic review
Grandi, G., Mueller, M. D., Bersinger, N. A., Cagnacci, A., Volpe, A., & McKinnon, B. D. (2015) · Inflammation Research · doi:10.1007/s00011-015-0909-7 · Cited by 94
Self-citationFraser, I. S., Römer, T., Parke, S., Zeun, S., Mellinger, U., Machlitt, A., & Jensen, J. T. (2011) · Human Reproduction · doi:10.1093/humrep/der224 · Cited by 93
Sex hormone‐binding globulin as a marker for the thrombotic risk of hormonal contraceptives
Raps, M., Helmerhorst, F. M., Fleischer, K., Thomassen, S., Rosendaal, F. R., Rosing, J., Ballieux, B. E. P. B., & van Vliet, H. A. A. M. (2012) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2012.04720.x · Cited by 87
Wilson, E., CRUICKSHANK, J., MCMASTER, M., & Weir, R. J. (1984) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1984.tb04747.x · Cited by 84
Current status of contraceptive vaginal rings
Brache, V., Payán, L. J., & Faúndes, A. (2012) · Contraception · doi:10.1016/j.contraception.2012.08.037 · Cited by 80
Lindberg, U.-B., Crona, N., Stigendal, L., Teger‐Nilsson, A. ‐., & Silfverstolpe, G. (1989) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1646528 · Cited by 80
Morin-Papunen, L., Martikainen, H., McCarthy, M. I., Franks, S., Sovio, U., Hartikainen, A.-L., Ruokonen, A., Leinonen, M., Laitinen, J., Järvelin, M.-R., et al. (2008) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2008.04.013 · Cited by 78
Endrikat, J., Parke, S., Trummer, D., Schmidt, W., Duijkers, I. J. M., & Klipping, C. (2008) · Contraception · doi:10.1016/j.contraception.2008.05.004 · Cited by 77
Farley, T. (1999) · Human Reproduction Update · doi:10.1093/humupd/5.6.721 · Cited by 77
Conard, J., Basdevant, A., Thomas, J.-L., Ochsenbein, E., Denis, C., Guyene, T. T., & Degrelle, H. (1995) · Fertility and Sterility · doi:10.1016/s0015-0282(16)57909-6 · Cited by 74
Oral contraceptive use and bone density in adolescent and young adult women
Scholes, D., Ichikawa, L., LaCroix, A. Z., Spangler, L., Beasley, J. M., Reed, S. D., & Ott, S. M. (2009) · Contraception · doi:10.1016/j.contraception.2009.07.001 · Cited by 74
The Metabolism of Estrogens in Normal Women After Pulse Injections of3H-Estradiol and3H-Estrone
Longcope, C., & Williams, K. I. H. (1974) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-38-4-602 · Cited by 72
Cagnacci, A., Paoletti, A. M., Renzi, A., Orrù, M., Pilloni, M., Melis, G. B., & Volpe, A. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030328 · Cited by 69
Self-citationGranese, R., Perino, A., Calagna, G., Saitta, S., FRANCISCIS, P. D., Colacurci, N., Triolo, O., & Cucinella, G. (2015) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/aogs.12633 · Cited by 66
Cagnacci, A., Ferrari, S., Tirelli, A., Zanin, R., & Volpe, A. (2008) · Contraception · doi:10.1016/j.contraception.2008.09.002 · Cited by 64
Self-citationSafety Evaluation of Modern Oral Contraceptives
Crook, D., & Godsland, I. F. (1998) · Contraception · doi:10.1016/s0010-7824(98)00018-3 · Cited by 63
Couzinet, B., Young, J., Kujas, M., Meduri, G., Brailly, S., Thomas, J. L., Chanson, P., & SCHAISON, G. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.11.6162 · Cited by 62
Basdevant, A., Pelissier, C., Conard, J., Degrelle, H., Guyene, T. T., & Thomas, J.-L. (1991) · Contraception · doi:10.1016/0010-7824(91)90080-y · Cited by 58
Review of clinical experience with estradiol in combined oral contraceptives
Fruzzetti, F., & Bitzer, J. (2009) · Contraception · doi:10.1016/j.contraception.2009.08.010 · Cited by 58
Endrikat, J., Klipping, C., Cronin, M., Gerlinger, C., Ruebig, A., Schmidt, W., & Düsterberg, B. (2002) · Contraception · doi:10.1016/s0010-7824(01)00316-x · Cited by 57
Pharmacokinetic evaluation of desogestrel as a female contraceptive
Grandi, G., Cagnacci, A., & Volpe, A. (2013) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2013.844229 · Cited by 53
Self-citationEffect of dienogest-containing oral contraceptives on lipid metabolism
Wiegratz, I., Lee, J. H., Kutschera, E., Bauer, H., Hayn, C., Moore, C., Mellinger, U., Winkler, U. H., Gross, W., & Kühl, H. (2002) · Contraception · doi:10.1016/s0010-7824(01)00310-9 · Cited by 49
Godsland, I. F., Crook, D., Devenport, M., & Wynn, V. (1995) · Contraception · doi:10.1016/0010-7824(95)00153-2 · Cited by 48
Bazin, B., Thévenot, R., Cd, B., & Pâris, J. (1987) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1987.tb02322.x · Cited by 48
The pharmacology of nomegestrol acetate
Ruan, X., Seeger, H., & Mueck, A. O. (2012) · Maturitas · doi:10.1016/j.maturitas.2012.01.007 · Cited by 47
Oral contraceptives and lipids.
Fotherby, K. (1989) · BMJ · doi:10.1136/bmj.298.6680.1049 · Cited by 47
Lete, I., Chabbert‐Buffet, N., Jamin, C., Lello, S., Lobo, P., Nappi, R. E., & Pintiaux, A. (2015) · The European Journal of Contraception & Reproductive Health Care · doi:10.3109/13625187.2015.1050091 · Cited by 47
Grandi, G., Xholli, A., Napolitano, A., Palma, F., & Cagnacci, A. (2014) · Reproductive Sciences · doi:10.1177/1933719114556488 · Cited by 47
Self-citationvan Rooijen, M., von Schoultz, B., Silveira, A. M. V., Hamsten, A., & Bremme, K. A. (2002) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2002.119179 · Cited by 46
Luque‐Ramírez, M., Mendieta-Azcona, C., Álvarez‐Blasco, F., & Escobar-Morreale, H. F. (2008) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.03.082 · Cited by 46
Straznicky, N. E., Barrington, V. E., Branley, P., & Louis, W. J. (1998) · Journal of Hypertension · doi:10.1097/00004872-199816030-00013 · Cited by 43
Effects of estrogens and progestogens on lipid metabolism
Oster, P., Arab, L., Kohlmeier, M., Mordasini, R., Schellenberg, B., & Schlierf, G. (1982) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(16)32487-5 · Cited by 40
Grandi, G., Piacenti, I., Volpe, A., & Cagnacci, A. (2014) · Gynecological Endocrinology · doi:10.3109/09513590.2014.922947 · Cited by 40
Self-citationWitjes, H., Creinin, M. D., Poromaa, I. S., Nguyen, A. M., & Korver, T. (2015) · The European Journal of Contraception & Reproductive Health Care · doi:10.3109/13625187.2015.1016154 · Cited by 37
Effect of a new oral contraceptive with estradiol valerate/dienogest on carbohydrate metabolism
Leo, V. D., Fruzzetti, F., Musacchio, M. C., Scolaro, V., Sabatino, A. D., & Morgante, G. (2013) · Contraception · doi:10.1016/j.contraception.2012.09.003 · Cited by 37
Sørdal, T., Grob, P. R., & Verhoeven, C. (2012) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/j.1600-0412.2012.01498.x · Cited by 34
Influence of an oral contraceptive containing drospirenone on insulin sensitivity of healthy women
Cagnacci, A., Piacenti, I., Zanin, R., Xholli, A., & Tirelli, A. (2014) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2014.03.021 · Cited by 28
Self-citationCagnacci, A., Ferrari, S., Napolitano, A., Piacenti, I., Arangino, S., & Volpe, A. (2012) · Contraception · doi:10.1016/j.contraception.2012.12.002 · Cited by 27
Self-citationGrandi, G., Xholli, A., Napolitano, A., Piacenti, I., Bellafronte, M., & Cagnacci, A. (2014) · Contraception · doi:10.1016/j.contraception.2014.05.011 · Cited by 26
Self-citationRaps, M., Rosendaal, F. R., Ballieux, B. E. P. B., Rosing, J., Thomassen, S., Helmerhorst, F. M., & van Vliet, H. A. A. M. (2013) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12172 · Cited by 24
Grandi, G., Napolitano, A., Xholli, A., Tirelli, A., Carlo, C. D., & Cagnacci, A. (2015) · Gynecological Endocrinology · doi:10.3109/09513590.2015.1063118 · Cited by 21
Self-citationCagnacci, A., Zanin, R., Napolitano, A., Arangino, S., & Volpe, A. (2013) · Contraception · doi:10.1016/j.contraception.2013.04.003 · Cited by 21
Self-citationFuchs, N., Düsterberg, B., Weber-Diehl, F., & Mühe, B. (1995) · Contraception · doi:10.1016/0010-7824(95)00097-t · Cited by 20
Carlo, C. D., Gargano, V., Sparice, S., Tommaselli, G. A., Bifulco, G., Schettino, D., & Nappi, C. (2013) · The European Journal of Contraception & Reproductive Health Care · doi:10.3109/13625187.2013.811483 · Cited by 18
Brache, V., Merkatz, R. B., Kumar, N., Jesam, C., Sussman, H., Hoskin, E. K., Roberts, K. D., Alami, M., Taylor, D., Jorge, A., et al. (2015) · Contraception · doi:10.1016/j.contraception.2015.05.011 · Cited by 17
Brennan, J. J., Lu, Z., Whitman, M. M., Stafiniak, P., & van der Hoop, R. G. (2001) · Therapeutic Drug Monitoring · doi:10.1097/00007691-200104000-00007 · Cited by 14
Oral contraceptives and bone metabolism
Volpe, A., Malmusi, S., Zanni, A. L., Landi, S., & Cagnacci, A. (1997) · The European Journal of Contraception & Reproductive Health Care · doi:10.3109/13625189709165298 · Cited by 12
Self-citationIs lipid profile determination necessary in women wishing to use oral contraceptives?
Machado, R. B., Bernardes, C. R., de Souza, I. M., Santana, N., & Morimoto, M. (2012) · Contraception · doi:10.1016/j.contraception.2012.12.003 · Cited by 7
Research works printed but not linked: 6
- Oelkers W, 1995, J Clin Endocrinol Metab, 80, 1816
- Lopez LM, 2014, Cochrane Database Syst Rev, 4, CD006133
- Godsland IF, 1992, J Clin Endocrinol Metab, 74, 64
- Lindberg UB, 1989, Thromb Haemost, 6, 65
- Commitee for medicinal products for human use (CHMP). Guideline on clinical investigation of steroid contraceptives in women
- Gambacciani M, 1994, Obstet Gynecol, 83, 392
Cited by
Armanini, D., Boscaro, M., Bordin, L., & Sabbadin, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084110 · Cited by 324
Endocrine and metabolic effects of an oral contraceptive containing estetrol and drospirenone
Klipping, C., Duijkers, I., Mawet, M., Maillard, C., Bastidas, A., Jost, M., & Foidart, J.-M. (2021) · Contraception · doi:10.1016/j.contraception.2021.01.001 · Cited by 108
Reed, S., Koro, C. E., DiBello, J. R., Becker, K., Bauerfeind, A., Franke, C., & Heinemann, K. (2021) · The European Journal of Contraception & Reproductive Health Care · doi:10.1080/13625187.2021.1987410 · Cited by 77
Mihajlovic, J., Leutner, M., Hausmann, B., Köhl, G., Schwarz, J., Röver, H., Stimakovits, N. M., Wolf, P. S., Maruszczak, K., Bastian, M., et al. (2021) · Environmental Microbiology · doi:10.1111/1462-2920.15517 · Cited by 62
Douxfils, J., Morimont, L., & Bouvy, C. (2020) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0040-1714140 · Cited by 48
Metadata
- Authors
- Grandi, G., Napolitano, A., & Cagnacci, A.
- Affiliations
- Azienda Ospedaliero-Universitaria di Modena (IT)
- Corresponding author
- Grandi, Giovanni
- Venue
- Expert Opinion on Drug Metabolism & Toxicology
- Publisher
- Informa UK Limited
- Published
- 2016-06
- Volume
- 12
- Issue
- 7
- Pages
- 779-787
- ISSN
- 1742-5255 (ISSN-L)
- 1744-7607
- OpenAlex
- W2399358581
- Cited by
- 50
- References
- 71
- Citations by year
- 2026: 4 · 2025: 6 · 2024: 3 · 2023: 11 · 2022: 5 · 2021: 7 · 2020: 6 · 2019: 3 · 2018: 1 · 2017: 3
- FWCI
- 2.31
- Type
- journal article
- Language
- en
- Open access
- green
- hdl.handle.net
- Licence
- cc-by
- Locations
- Expert Opinion on Drug Metabolism & Toxicology (publishedVersion)
- PubMed (publishedVersion)
- Institutional Research Information System (University of Udine) (submittedVersion)
- CINECA IRIS Institutial Research Information System (University of Genoa) (submittedVersion)
- IRIS UNIMORE (University of Modena and Reggio Emilia) (submittedVersion, cc-by)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Reproductive Health and Contraception
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Keywords
- estradiol, ethinyl estradiol, combined hormonal contraceptives, oral contraceptives, nomegestrol acetate, estradiol valerate, dienogest, lipid metabolism, hemostasis, blood pressure, bone metabolism, cardiovascular events, bone fractures, transdermal estradiol, vaginal estradiol, Nestorone, progestins
- MeSH terms
- Blood Pressure, Contraceptives, Oral, Combined, Contraceptives, Oral, Hormonal, Estradiol, Ethinyl Estradiol, Hemostasis, Humans, Megestrol, Nandrolone, Norpregnadienes, Lipid Metabolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.